+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure

Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure

Drug Metabolism and Pharmacokinetics 22(6): 419-427

We previously reported that MEEK, a generic product of vancomycin hydrochloride (VCM), was less nephrotoxic than a conventional preparation (S-VCM) in normal rats at a nephrotoxic dose (400 mg/kg) of VCM.(1)) To infer the clinical significance of this finding, we compared the risk of nephrotoxicity of these two formulations in rats with chronic renal failure in this study. MEEK or S-VCM was given intravenously to two weeks post-5/6 nephrectomy rats, and the pharmacokinetic profile of VCM and pathological evaluation were compared. There were no differences at the daily clinical dose (40 mg/kg), but at the twice the daily clinical dose (80 mg/kg), the mean plasma concentration of VCM was higher after S-VCM administration than after MEEK and the CL(tot) and CL(r) decreased to approximately 60% of those after MEEK. The renal tissue concentration of VCM was 1.5-fold higher at 24hr after S-VCM administration than after MEEK. Pathologically, no marked differences between the findings were observed at 24hr after administration of each formulation. These findings suggest that MEEK reduces renal damage caused by VCM and prevents the iatrogenic aggravation of nephrotoxicity. These results hold out hope that MEEK will permit high-dose administration of VCM, while revealing clinical significance of the nephrotoxicity-reduction by MEEK.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052462383

Download citation: RISBibTeXText

PMID: 18159129

DOI: 10.2133/dmpk.22.419

Related references

Decreased cyclosporin A concentrations in the absorption phase using microemulsion preconcentrate formulation in rats with cisplatin-induced acute renal failure. Biological and Pharmaceutical Bulletin 26(11): 1591-1595, 2003

Decreased nitric oxide synthesis in rats with chronic renal failure. Journal of Korean Medical Science 15(4): 425-430, 2000

Gastric emptying of solids but not liquids is decreased in rats with chronic renal failure. Digestive Diseases & Sciences 39(11): 2301-2305, 1994

Effect of electroacupuncture intervention on renal function and expression of renal beta-catenin in rats with chronic renal failure. Zhen Ci Yan Jiu 39(5): 396-400, 2014

Decreased transport of p-aminohippurate in renal basolateral membranes isolated from rats with acute renal failure. Pharmaceutical Research 6(11): 954-957, 1989

Increased plasma levels of alpha-1-acid glycoprotein in chronic renal failure are unlikely to be due to decreased renal elimination. Nephron 42(4): 345-346, 1986

Renal handling of drugs in renal failure. I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats. Journal of Pharmacology and Experimental Therapeutics 246(3): 896-901, 1988

Children with chronic renal failure in the Federal Republic of Germany: II. Primary renal diseases, age and intervals from early renal failure to renal death. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Clinical Nephrology 23(6): 278-284, 1985

Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure. Circulation Research 62(1): 155-161, 1988

Decreased endothelial nitric oxide synthase in gastric mucosa of rats with chronic renal failure. American Journal of Physiology 274(6): F1102, 1998

Effect of chronic accumulation of aluminum on renal function, cortical renal oxidative stress and cortical renal organic anion transport in rats. Archives of Toxicology 77(11): 605-612, 2003

Effect of oral adsorbent AST-120 in rats with chronic renal failure--mechanism of progression of renal failure by dietary protein. Nihon Jinzo Gakkai Shi 34(3): 261-271, 1992

Recovery of decreased ability of peripheral-blood mononuclear cells from chronic renal failure to produce interleukin-1 alpha and beta after renal transplantation. Nephron 58(4): 450-455, 1991

The dose-dependent effects of benazepril, an angiotensin converting enzyme inhibitor, on the improvement of renal function in chronic renal failure in 5/6 renal ablated normotensive Sprague Dawley rats. FASEB Journal 9(4): A685, 1995

Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. Cooperative Study Group of Pubertal development in Chronic Renal Failure. Journal of Clinical Endocrinology and Metabolism 78(6): 1298-1306, 1994